David Meeker - President and CEO, Rhythm Pharmaceuticals, Inc

As of March 31, 2021


David Meeker Net Worth

  • Net worth is estimated to be at least $1.87M
  • Owns at least 111,335 units of Rhythm Pharmaceuticals, Inc stock

David Meeker Compensation at Rhythm Pharmaceuticals, Inc in 2020

  • Earned a $262,308 salary
  • Rewarded $918,500 in stock value and options
  • Received a total compensation of $13,358,867

David Meeker Trading

  • Largest purchase of shares was 79,525 units , worth over $425K on October 10, 2017
  • In total has made about 7 transactions over 4 years
  • Usually trades in June, with the busiest year in 2020 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

David Meeker Mailing Address

  • Mailing address is C/o Penwest Pharmaceuticals Co 39 Old Ridgebury Road Suite 11 Danbury CT 06810 CT

Rhythm Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David P. Meeker, M.D. 2020 $262,308 - $918,500 $12,844,897 $207,958 $43,704 $13,358,867
Keith M. Gottesdiener, M.D. 2020 $142,906 - - $2,810,726 - $495,537 $3,449,169
Keith M. Gottesdiener, M.D. 2019 $525,934 - - $4,133,768 $277,340 - $4,937,042
Hunter C. Smith 2020 $416,118 $60,000 $132,000 $1,837,630 $209,595 $7,125 $2,530,468
Hunter C. Smith 2019 $396,992 - - $1,286,061 $153,224 $86,576 $1,922,853
Murray Stewart, D.M., F.R.C.P. 2020 $451,169 $60,000 $113,000 $1,555,420 $226,600 $7,125 $2,300,314
Jennifer Chien 2020 $45,577 $100,000 $100,000 $1,517,540 $49,375 - $1,712,492
Nithya Desikan 2020 $305,510 - $105,000 $1,533,841 - $104,620 $1,943,971
Nithya Desikan 2019 $379,063 - - $1,286,061 $145,117 - $1,810,241
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1649904/000110465921055591/tm212464-1_def14a.htm

Rhythm Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 1,023 units sold on March 31, 2022 by William T Roberts worth over $11.39K
  • In the last 5 years, insiders at Rhythm Pharmaceuticals, Inc sold an estimated value of $75.41M and bought an estimated value of $108.59M
  • The most active traders are Todd Foley, Director,  Keith M. Gottesdiener, CEO & President,  and Hunter C Smith, Chief Financial Officer
  • Insider trading is most common in February, with the busiest year in 2020

RHYTHM PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1